April 4 - 5, 2024 
San Diego Convention Center • San Diego, CA About this event
This Event is put on by the American Association for Cancer Research.
Cochairs:
Michael A. Caligiuri, City of Hope, Duarte, CA
Christiana Bardon, MPM | BioImpact Capital, Boston, MA
William N. Hait, Johnson & Johnson, New Brunswick, NJ
Register today for the Inaugural AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients, where leading pharmaceutical and biotechnology companies will present their oncology-focused pipelines, emerging scientific themes across the biopharmaceutical industry, and areas for future research. Bringing together industry partners, researchers, venture capitalists, and investors in one venue, this must-attend event will provide a unique opportunity to hear about the future of oncology drug development from leading R&D experts and explore partnerships that will accelerate progress in treatments.
The AACR is committed to bridging the gap between cancer research, pharma, and patients through innovation and collaboration, and this inaugural event provides a platform for the advancement of key relationships in the biopharmaceutical industry, with the goal of ultimately bringing discoveries closer to patients.
Please note, the Inaugural AACR Oncology Industry Partnering Event requires a separate registration from the AACR Annual Meeting 2024 and will be live-streamed. The program will be updated periodically as additional companies, sessions, and presenters are confirmed.